Literature DB >> 19729360

Early life origins of chronic obstructive pulmonary disease.

C Svanes1, J Sunyer, E Plana, S Dharmage, J Heinrich, D Jarvis, R de Marco, D Norbäck, C Raherison, S Villani, M Wjst, K Svanes, J M Antó.   

Abstract

BACKGROUND: Early life development may influence subsequent respiratory morbidity. The impact of factors determined in childhood on adult lung function, decline in lung function and chronic obstructive pulmonary disease (COPD) was investigated.
METHODS: European Community Respiratory Health Survey participants aged 20-45 years randomly selected from general populations in 29 centres underwent spirometry in 1991-3 (n = 13 359) and 9 years later (n = 7738). Associations of early life factors with adult forced expiratory volume in 1 s (FEV(1)), FEV(1) decline and COPD (FEV(1)/FVC ratio <70% and FEV(1) <80% predicted) were analysed with generalised estimating equation models and random effects linear models.
RESULTS: Maternal asthma, paternal asthma, childhood asthma, maternal smoking and childhood respiratory infections were significantly associated with lower FEV(1) and defined as "childhood disadvantage factors"; 40% had one or more childhood disadvantage factors which were associated with lower FEV(1) (men: adjusted difference 95 ml (95% CI 67 to 124); women: adjusted difference 60 ml (95% CI 40 to 80)). FEV(1) decreased with increasing number of childhood disadvantage factors (> or =3 factors, men: 274 ml (95% CI 154 to 395), women: 208 ml (95% CI 124 to 292)). Childhood disadvantage was associated with a larger FEV(1) decline (1 factor: 2.0 ml (95% CI 0.4 to 3.6) per year; 2 factors: 3.8 ml (95% CI 1.0 to 6.6); > or =3 factors: 2.2 ml (95% CI -4.8 to 9.2)). COPD increased with increasing childhood disadvantage (1 factor, men: OR 1.7 (95% CI 1.1 to 2.6), women: OR 1.6 (95% CI 1.01 to 2.6); > or =3 factors, men: OR 6.3 (95% CI 2.4 to 17), women: OR 7.2 (95% CI 2.8 to 19)). These findings were consistent between centres and when subjects with asthma were excluded.
CONCLUSIONS: People with early life disadvantage have permanently lower lung function, no catch-up with age but a slightly larger decline in lung function and a substantially increased COPD risk. The impact of childhood disadvantage was as large as that of heavy smoking. Increased focus on the early life environment may contribute to the prevention of COPD.

Entities:  

Mesh:

Year:  2009        PMID: 19729360     DOI: 10.1136/thx.2008.112136

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  110 in total

1.  Evaluation and management of pulmonary disease in ataxia-telangiectasia.

Authors:  Sharon A McGrath-Morrow; W Adam Gower; Cynthia Rothblum-Oviatt; Alan S Brody; Claire Langston; Leland L Fan; Maureen A Lefton-Greif; Thomas O Crawford; Michelle Troche; John T Sandlund; Paul G Auwaerter; Blaine Easley; Gerald M Loughlin; John L Carroll; Howard M Lederman
Journal:  Pediatr Pulmonol       Date:  2010-09

2.  Patterns of Growth and Decline in Lung Function in Persistent Childhood Asthma.

Authors:  M J McGeachie; K P Yates; S T Weiss; R C Strunk; X Zhou; F Guo; A L Sternberg; M L Van Natta; R A Wise; S J Szefler; S Sharma; A T Kho; M H Cho; D C Croteau-Chonka; P J Castaldi; G Jain; A Sanyal; Y Zhan; B R Lajoie; J Dekker; J Stamatoyannopoulos; R A Covar; R S Zeiger; N F Adkinson; P V Williams; H W Kelly; H Grasemann; J M Vonk; G H Koppelman; D S Postma; B A Raby; I Houston; Q Lu; A L Fuhlbrigge; K G Tantisira; E K Silverman; J Tonascia
Journal:  N Engl J Med       Date:  2016-05-12       Impact factor: 91.245

3.  Combined Impact of Smoking and Early-Life Exposures on Adult Lung Function Trajectories.

Authors:  James P Allinson; Rebecca Hardy; Gavin C Donaldson; Seif O Shaheen; Diana Kuh; Jadwiga A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

Review 4.  The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  James C Hogg; Peter D Paré; Tillie-Louise Hackett
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

5.  A Multiple Indicators Multiple Cause (MIMIC) model of respiratory health and household factors in Chinese children: the seven Northeastern cities (SNEC) study.

Authors:  Guang-Hui Dong; Zhengmin Qian; Qiang Fu; Jing Wang; Edwin Trevathan; Wenjun Ma; Miao-Miao Liu; Da Wang; Wan-Hui Ren; Kee-Hean Ong; Tekeda Freeman Ferguson; Erin Riley; Maayan Simckes
Journal:  Matern Child Health J       Date:  2014-01

6.  Characterisation of asthma that develops during adolescence; findings from the Isle of Wight Birth Cohort.

Authors:  Ramesh J Kurukulaaratchy; Abid Raza; Martha Scott; Paula Williams; Susan Ewart; Sharon Matthews; Graham Roberts; S Hasan Arshad
Journal:  Respir Med       Date:  2011-12-31       Impact factor: 3.415

7.  A Distinct Low Lung Function Trajectory from Childhood to the Fourth Decade of Life.

Authors:  Cristine E Berry; Dean Billheimer; Isaac C Jenkins; Zhenqiang J Lu; Debra A Stern; Lynn B Gerald; Tara F Carr; Stefano Guerra; Wayne J Morgan; Anne L Wright; Fernando D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2016-09-01       Impact factor: 21.405

Review 8.  Evaluation of Individuals at Risk for COPD: Beyond the Scope of the Global Initiative for Chronic Obstructive Lung Disease.

Authors:  Julio D Antuni; Peter J Barnes
Journal:  Chronic Obstr Pulm Dis       Date:  2016-06-28

9.  Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality.

Authors:  Jacob Louis Marott; Truls Sylvan Ingebrigtsen; Yunus Çolak; Jørgen Vestbo; Peter Lange
Journal:  Am J Respir Crit Care Med       Date:  2020-07-15       Impact factor: 21.405

10.  Secreted phosphoprotein 1 is a determinant of lung function development in mice.

Authors:  Koustav Ganguly; Timothy M Martin; Vincent J Concel; Swapna Upadhyay; Kiflai Bein; Kelly A Brant; Leema George; Ankita Mitra; Tania A Thimraj; James P Fabisiak; Louis J Vuga; Cheryl Fattman; Naftali Kaminski; Holger Schulz; George D Leikauf
Journal:  Am J Respir Cell Mol Biol       Date:  2014-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.